AVXL Covered Call Strategy
AVXL (Anavex Life Sciences Corp.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Operating as a clinical-stage biopharmaceutical entity, Anavex Life Sciences Corp. specializes in developing therapeutic drug candidates for various central nervous system (CNS) conditions. Its leading compound, ANAVEX 2-73, is currently in advanced development, undergoing Phase III clinical evaluation for both Alzheimer's disease and pediatric Rett syndrome. This same drug is also in Phase II trials for Parkinson's disease and is being explored in preclinical studies for a wider range of disorders, including epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. Another significant drug candidate, ANAVEX 3-71, has progressed to Phase I clinical trials for frontotemporal dementia and other forms of dementia, with additional preclinical investigation underway for neurodegenerative illnesses like Alzheimer's and Parkinson's. The company's earlier-stage portfolio includes ANAVEX 1-41, a sigma-1 receptor agonist targeting depression, stroke, Parkinson's, and Alzheimer's diseases; ANAVEX 1066, a mixed sigma-1/sigma-2 ligand with potential applications in neuropathic and visceral pain; and ANAVEX 1037, aimed at treating prostate and pancreatic cancers. Anavex Life Sciences Corp. was founded in 2004 and maintains its headquarters in New York, New York.
AVXL (Anavex Life Sciences Corp.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $242.8M, a beta of 1.12 versus the broader market, a 52-week range of 2.41-13.99, average daily share volume of 1.2M, a public-listing history dating back to 2006, approximately 42 full-time employees. These structural characteristics shape how AVXL stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.12 places AVXL roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a covered call on AVXL?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current AVXL snapshot
As of June 30, 2026, spot at $2.63, ATM IV 179.20%, IV rank 32.20%, expected move 51.38%. The covered call on AVXL below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this covered call structure on AVXL specifically: AVXL IV at 179.20% is mid-range versus its 1-year history, so the credit collected on a AVXL covered call sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 51.38% (roughly $1.35 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AVXL expiries trade a higher absolute premium for lower per-day decay. Position sizing on AVXL should anchor to the underlying notional of $2.63 per share and to the trader's directional view on AVXL stock.
AVXL covered call setup
The AVXL covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AVXL near $2.63, the first option leg uses a $2.76 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AVXL chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AVXL shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $2.63 | long |
| Sell 1 | Call | $2.76 | N/A |
AVXL covered call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
AVXL covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on AVXL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use covered call on AVXL
Covered calls on AVXL are an income strategy run on existing AVXL stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
AVXL thesis for this covered call
The market-implied 1-standard-deviation range for AVXL extends from approximately $1.28 on the downside to $3.98 on the upside. A AVXL covered call collects premium on an existing long AVXL position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether AVXL will breach that level within the expiration window. Current AVXL IV rank near 32.20% is mid-range against its 1-year distribution, so the IV signal is neutral; the covered call thesis on AVXL should anchor more to the directional view and the expected-move geometry. As a Healthcare name, AVXL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AVXL-specific events.
AVXL covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AVXL positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AVXL alongside the broader basket even when AVXL-specific fundamentals are unchanged. Short-premium structures like a covered call on AVXL carry tail risk when realized volatility exceeds the implied move; review historical AVXL earnings reactions and macro stress periods before sizing. Always rebuild the position from current AVXL chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on AVXL?
- A covered call on AVXL is the covered call strategy applied to AVXL (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With AVXL stock trading near $2.63, the strikes shown on this page are snapped to the nearest listed AVXL chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are AVXL covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the AVXL covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 179.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a AVXL covered call?
- The breakeven for the AVXL covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current AVXL market-implied 1-standard-deviation expected move is approximately 51.38%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on AVXL?
- Covered calls on AVXL are an income strategy run on existing AVXL stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current AVXL implied volatility affect this covered call?
- AVXL ATM IV is at 179.20% with IV rank near 32.20%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.